Every one of those 1 sits in a single category, funding. BioNEST is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 8 average consequence score is above the beat benchmark of 6.3 in the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Dr. Jitendra Singh
Every one of those 1 sits in a single category, funding. BioNEST is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 8 average consequence score is above the beat benchmark of 6.3 in the same window. Source depth averages 4 original sources per story, versus 2.9 across the same-window beat baseline. Dr. Jitendra Singh appears in 1 tracked Healthcare story from March 20, 2026.
Stories tracked
1
Sources per story
4
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Dr. Jitendra Singh. Shared-story counts are live from our verified record — not editorial picks.
The Biotechnology Industry Research Assistance Council (BIRAC) celebrated its 14th Foundation Day, announcing ₹4,200 crore in total funding enabled for over 15 lakh startups and entrepreneurs. This massive deployment of capital and infrastructure marks a pivotal moment in India's journey toward a $300 billion bio-economy by 2030.